Levels of interleukin-33 and interleukin-6 in patients with acute coronary syndrome or stable angina.

CLINICAL AND INVESTIGATIVE MEDICINE(2013)

引用 13|浏览5
暂无评分
摘要
Purpose: The purpose of this study was to investigate the levels of interleukin-33 (IL-33) and interleukin-6 (IL-6) in patients with acute coronary syndrome or stable angina. Methods: Serum IL-33 and IL-6 were measured with Enzyme Linked Immuosorbent Assay (ELISA) in patients with acute coronary syndrome (ACS, n = 40), and stable angina pectoris (SAP, n = 43). IL-33 and IL-6 were also determined in 30 healthy subjects (control group). Results: The serum level of IL-33 in the ACS group (78.60 +/- 44.84 ng/L) was lower than in the SAP (102.58 +/- 37.21 ng/L, P<0.01) or control groups (130.24 +/- 10.17 ng/L, P<0.01). The serum level of IL-6 in the ACS group (39.90 +/- 12.64 ng/L) was higher than in the SAP (18.68 +/- 11.89 ng/L, P<0.05) or control groups (6.28 +/- 17.72 ng/L, P<0.05). There were no differences in serum levels of IL-33 and IL-6 among the single-, double-and triple-vessel lesion groups. IL-33 and IL-6 levels were negatively correlated with each other in the ACS (r = -0.871, P<0.01) and SAP groups (r = -0.788, P<0.01). Conclusion: The serum level of IL-33 was lower in patients with ACS or SAP and was negatively correlated with the serum level of IL-6. Thus, IL-33 and IL-6 may be used as biomarkers for evaluating inflammatory response and severity of coronary heart disease in patients with ACS or SAP.
更多
查看译文
关键词
acute coronary syndrome,stable angina
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要